<DOC>
	<DOCNO>NCT01613235</DOCNO>
	<brief_summary>The objective multi-centre , randomize control trial investigate outcome induced hypertension versus induced hypertension patient delayed cerebral ischemia ( DCI ) aneurysmal subarachnoid hemorrhage ( SAH ) , assess whether induced hypertension result improve cerebral blood flow ( CBF ) measure mean perfusion-CT .</brief_summary>
	<brief_title>Induced Hypertension Treatment Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage</brief_title>
	<detailed_description>Background Subarachnoid haemorrhage ( SAH ) rupture cerebral aneurysm subset stroke poor prognosis . Delayed cerebral ischemia ( DCI ) major complication SAH around 30 % SAH patient increase case fatality 1.5 - 3 fold . One option treat DCI use induce hypertension , alone combination haemodilution hypervolemia , call Triple-H , efficacy induced hypertension reduce DCI base case series , randomise clinical trial . Objective To investigate outcome induced hypertension versus induced hypertension patient DCI aneurysmal SAH . Study design A multi-centre , single blind , randomize control trial . Study population Patients admit one participating centre recent SAH treat aneurysm DCI base onset new focal deficit and/or decrease level consciousness least 1 point Glasgow Coma Scale exclusion cause deterioration , randomize either hypertension ( n=120 ) hypertension ( n=120 ) . Interventions Patients arm 1 blood pressure raise order improve cerebral blood flow ( CBF ) . In case low cardiac output , inotropics add . Induced hypertension continue least 48 hour patient show improvement within first 24 hour . After 48 hour , dose vasopressor tapered daily , resume case clinical deterioration . In patient show improvement within 24 hour , induced hypertension continue . In patient arm 2 trial , hypertension induce . Patients arms trial treat oral nimodipine normovolaemia without haemodilution . In selected centre , extra perfusion CT scan perform 24-36 hour instalment treatment . Measurement CBF perform participant perfusion CT-scanning brain beginning study ( part regular patient care ) , 24-36 hour . Main outcome measurement The modify Rankin scale 3 month SAH , compare patient randomize induced hypertension patient randomize induced hypertension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Inclusion criterion eligibility 1 . Admission one participate study centre . 2 . Age 18 year . 3 . SAH aneurysmatic bleeding pattern . Exclusion criterion eligibility 1 . Evidence DCI SAH , define decrease level consciousness development new focal neurological deficit onset SAH due increase hydrocephalus , rebleeding aneurysm , epileptic seizure , septic metabolic encephalopathy , unless symptom DCI start within 3 hour . 2 . Coexisting severe head injury . 3 . Perimesencephalic haemorrhage ( perimesencephalic bleeding pattern aneurysm CTangiography ) . 4 . A history ventricular cardiac rhythm disorder , necessitate medical treatment . 5 . A history leave ventricular heart failure , necessitate medical treatment . 6 . Likely transfer another hospital , participate trial , soon treatment aneurysm . 7 . Moribund . 8 . Pregnancy . And furthermore , select centre sub study CT perfusion perform : 9 . Known allergy CTcontrast agent . 10 . Renal failure , define serum creatinine &gt; 150 Âµmol/l , risk contrast nephropathy . 11 . Diabetes mellitus . Inclusion criterion trial participation 1 . Informed consent participate propose trial DCI develop . 2 . DCI base decrease least one point Glasgow Coma Scale sum score unless decrease n't reflect DCI evaluate treat physician , and/or development new focal neurological deficit , diagnosed neurologist , neurosurgeon intensivist . Exclusion criterion trial participation : 1 . Another cause neurological deterioration include . 2 . A symptomatic aneurysm yet treat coil clipping . 3 . Severe hypertension , define spontaneous MAP 120 mmHg moment evaluation trial participation . 4 . Any contraindication induce hypertension ( cardiac complication necessitate medical treatment ) evaluate treat physician . And furthermore , select centre sub study CT perfusion perform : 5 . No CTP scan time neurological deterioration . 6 . More 3 CTP scan since admission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>ischemia</keyword>
	<keyword>vasospasm</keyword>
	<keyword>CT</keyword>
	<keyword>perfusion</keyword>
	<keyword>induced hypertension</keyword>
	<keyword>delay cerebral ischemia</keyword>
</DOC>